Skip to main content
. 2023 Jul 10;9:23779608231187248. doi: 10.1177/23779608231187248

Table 4.

Comparison Between Weaning Groups, and Between the Mortality Outcome 28 Days Groups According to Laboratory Investigations.

laboratory Investigations Total
(n = 90)
Weaning p Mortality Outcome 28 days p
Weaning Success
(n = 50)
Weaning Failure
(n = 40)
Survival
(n = 45)
Died
(n = 45)
Complete blood picture
Lymphocytic count:
Median (Min.–Max.)
1 (0.50–4.10) 1.30 (0.60–4.10) 0.95 (0.50–2.70) .058 1.40 (0.60–4.10) 0.90 (0.50 –2.70) .003*
WBC: Median (Min.–Max.) 7.30 (2.17–29.0) 6.95 (2.17–27.0) 7.45 (2.30–29.0) .620 6.40 (2.17–27.0) 7.50 (2.30 –29.0) .958
Coagulation studies
INR: Median (Min.–Max.) 1.12 (0.90–2.84) 1.21 (0.90–2.40) 1.02 (0.94–2.84) .006* 1.20 (0.90–2.40) 1.05 (0.94 –2.84) .020*
PLT: Median (Min.–Max.) 206 (46–473) 216 (76–473) 188 (46–435) .111 214.0 (76–473) 198 (46–435) .292
Renal function test
Creatinine Median
(Min.–Max.)
107 (40–498) 110.5 (40.–498) 107 (45–372) .868 124 (40–498) 106 (45–372) .532
Urea Median (Min.–Max.) 24.1 (10–104) 24.4 (10–57) 23.2 (10–104) .567 24.50 (10–57) 23 (10–104) .910
Liver function test
ALT: Median (Min.–Max.) 50 (11–1103) 42.5 (11–498) 68 (13–1103) .014* 43 (11–498) 56 (13.– 1103) .042*
AST: Median (Min.–Max.) 66 (16–526) 51 (16–337) 78 (16–526) .057 51 (16–337) 78 (16–526) .135
Lactate Median (Min.–Max.) 4.30 (1.70–15.0) 4.30 (1.80–8.10) 4.35 (1.70–15.0) .482 4.30 (1.80–8.10) 4.20 (1.70 –15.0) .981
Albumin: Mean ± SD 3.44 ± 0.77 3.59 ± 0.70 3.25 ± 0.82 .032* 3.62 ± 0.69 3.26 ± 0.82 .027*
BIL: Median (Min.–Max.) 1 (0.60–3.30) 1 (0.60–2.60) 0.95 (0.60–3.30) .365 1 (0.60–2.60) 0.90 (0.60 –3.30) .238
IL6: Median (Min.–Max.) 4.86 (0.54 −31.21) 4.98 (0.54–15.08) 4.72 (1.14 −31.21) .868 4.73 (0.54 15.08) 5.08 (1.14 31.21) .591

Abbreviations: SD = standard deviation; χ2 = chi-square test; t = Student t-test; U = Mann Whitney test; p = p-value for comparing between weaned and not weaned.

*: Statistically significant at p ≤ .05.